Coston, Mc Isaac & Partners Vertex Pharmaceuticals Inc Transaction History
Coston, Mc Isaac & Partners
- $288 Million
- Q1 2025
A detailed history of Coston, Mc Isaac & Partners transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Coston, Mc Isaac & Partners holds 14 shares of VRTX stock, worth $6,451. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 14
-0.0%
Holding current value
$6,451
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,826Shares Held
231MCall Options Held
1.49MPut Options Held
1.07M-
Capital World Investors Los Angeles, CA28.5MShares$13.1 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.8 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.82 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.7 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.43 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $118B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...